Literature DB >> 17243958

Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment.

M Jones-Caballero1, M M Chren, B Soler, E Pedrosa, P F Peñas.   

Abstract

BACKGROUND: Because of its effects on quality of life, acne vulgaris is more than a merely physiological or cosmetic entity.
OBJECTIVES: To describe the influence of mild to moderate acne on patients' quality of life, measured using Skindex-29, and to correlate changes in Skindex-29 scores with changes in objective and subjective indices in clinical severity after treatment with topical 4% erythromycin 0.2% zinc. Also, to evaluate efficacy and side-effects of the treatment.
METHODS: Observational, prospective study of 1878 patients cared for by 252 clinicians in Spain. Data included epidemiological information and responses to Skindex-29, a subjective change and objective severity index.
RESULTS: Baseline Skindex scale scores were worse in women, older patients, and those with more severe clinical disease. Skindex was sensitive to changes in objective severity but changes in Skindex scale scores were also related to other factors. Patients who reported their skin condition to be 'the same' or 'worse' at the end of the study had significantly worse baseline scores on the 'symptoms' and 'emotions' scales but 'functioning' scores were not worse than for those who reported their condition had improved.
CONCLUSION: The effects of acne vulgaris on quality of life and changes in quality of life after treatment are not only explainable by objective severity of acne. Patients' and clinicians' judgements about acne severity are different.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17243958     DOI: 10.1111/j.1468-3083.2006.01907.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  20 in total

1.  Management of acne: Canadian clinical practice guideline.

Authors:  Yuka Asai; Akerke Baibergenova; Maha Dutil; Shannon Humphrey; Peter Hull; Charles Lynde; Yves Poulin; Neil H Shear; Jerry Tan; John Toole; Catherine Zip
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

Review 2.  [Drug therapy of acne].

Authors:  F R Ochsendorf; K Degitz
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

3.  Impact of acne on quality of life of students at sultan qaboos university.

Authors:  Asma Al-Shidhani; Samia Al-Rashdi; Hamdan Al-Habsi; Syed Rizvi
Journal:  Oman Med J       Date:  2015-01

4.  A Four-question Approach to Determining the Impact of Acne Treatment on Quality of Life.

Authors:  Peter Saitta; Steven K Grekin
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

5.  A study on the prescribing pattern of drugs for acne in a tertiary care teaching hospital in odisha.

Authors:  Nibedita Patro; Monalisa Jena; Maitreyee Panda; Mrutyunjay Dash
Journal:  J Clin Diagn Res       Date:  2015-03-01

6.  Quality of life in cutaneous lupus erythematosus.

Authors:  Rachel Klein; Siamak Moghadam-Kia; Lynne Taylor; Christopher Coley; Joyce Okawa; Jonathan LoMonico; Mary-Margaret Chren; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-03-12       Impact factor: 11.527

7.  Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-severe Acne: An Update.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2012-01

8.  Assessment of temperament and character profile with anxiety and depression in patients with acne.

Authors:  Perihan Oztürk; Fatma Özlem Orhan; Ali Ozer; Tuğba Karakaş; Ali Nuri Oksüz; Nur Yalçın Yetişir
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

9.  Quality of life in adults with facial port-wine stains.

Authors:  Solveig L Hagen; Katherine R Grey; Dorota Z Korta; Kristen M Kelly
Journal:  J Am Acad Dermatol       Date:  2016-12-09       Impact factor: 11.527

10.  Quality of life evaluation in Japanese pregnant women with striae gravidarum: a cross-sectional study.

Authors:  Kotomi Yamaguchi; Nobuhiko Suganuma; Kazutomo Ohashi
Journal:  BMC Res Notes       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.